444 related articles for article (PubMed ID: 18761113)
1. Combined effects of recombinant human BMP-7 (rhBMP-7) and parathyroid hormone (1-34) in metaphyseal bone healing.
Morgan EF; Mason ZD; Bishop G; Davis AD; Wigner NA; Gerstenfeld LC; Einhorn TA
Bone; 2008 Dec; 43(6):1031-8. PubMed ID: 18761113
[TBL] [Abstract][Full Text] [Related]
2. The stimulation of healing within a rat calvarial defect by mPCL-TCP/collagen scaffolds loaded with rhBMP-2.
Sawyer AA; Song SJ; Susanto E; Chuan P; Lam CX; Woodruff MA; Hutmacher DW; Cool SM
Biomaterials; 2009 May; 30(13):2479-88. PubMed ID: 19162318
[TBL] [Abstract][Full Text] [Related]
3. Human parathyroid hormone (1-34) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora.
Komatsubara S; Mori S; Mashiba T; Nonaka K; Seki A; Akiyama T; Miyamoto K; Cao Y; Manabe T; Norimatsu H
Bone; 2005 Apr; 36(4):678-87. PubMed ID: 15781006
[TBL] [Abstract][Full Text] [Related]
4. Intermittent PTH(1-34) does not increase union rates in open rat femoral fractures and exhibits attenuated anabolic effects compared to closed fractures.
Tägil M; McDonald MM; Morse A; Peacock L; Mikulec K; Amanat N; Godfrey C; Little DG
Bone; 2010 Mar; 46(3):852-9. PubMed ID: 19922821
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of recombinant human BMP-7 bone formation with bmp binding peptide in a rodent femoral defect model.
Liao JC; Tzeng ST; Keorochana G; Lee KB; Johnson JS; Morishita Y; Murray SS; Wang JC
J Orthop Res; 2011 May; 29(5):753-9. PubMed ID: 21437956
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human bone morphogenetic protein-2 enhances osteotomy healing in glucocorticoid-treated rabbits.
Luppen CA; Blake CA; Ammirati KM; Stevens ML; Seeherman HJ; Wozney JM; Bouxsein ML
J Bone Miner Res; 2002 Feb; 17(2):301-10. PubMed ID: 11811561
[TBL] [Abstract][Full Text] [Related]
7. Increases in callus formation and mechanical strength of healing fractures in old rats treated with parathyroid hormone.
Andreassen TT; Fledelius C; Ejersted C; Oxlund H
Acta Orthop Scand; 2001 Jun; 72(3):304-7. PubMed ID: 11480610
[TBL] [Abstract][Full Text] [Related]
8. Manipulation of the anabolic and catabolic responses with OP-1 and zoledronic acid in a rat critical defect model.
Little DG; McDonald M; Bransford R; Godfrey CB; Amanat N
J Bone Miner Res; 2005 Nov; 20(11):2044-52. PubMed ID: 16234978
[TBL] [Abstract][Full Text] [Related]
9. Ability of recombinant human bone morphogenetic protein 2 to enhance bone healing in the presence of tobramycin: evaluation in a rat segmental defect model.
Glatt V; Kwong FN; Park K; Parry N; Griffin D; Vrahas M; Evans CH; Harris M
J Orthop Trauma; 2009; 23(10):693-701. PubMed ID: 19858977
[TBL] [Abstract][Full Text] [Related]
10. Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits.
Hirano T; Burr DB; Turner CH; Sato M; Cain RL; Hock JM
J Bone Miner Res; 1999 Apr; 14(4):536-45. PubMed ID: 10234574
[TBL] [Abstract][Full Text] [Related]
11. Action of recombinant human BMP-2 on fracture healing in rabbits is dependent on the mechanical environment.
Cuenca-López MD; Peris JL; García-Roselló M; Atienza C; Prat J; Becerra J; Andrades JA
J Tissue Eng Regen Med; 2010 Oct; 4(7):543-52. PubMed ID: 20209659
[TBL] [Abstract][Full Text] [Related]
12. Effects of OP-1 and PTH in a new experimental model for the study of metaphyseal bone healing.
Tsiridis E; Morgan EF; Bancroft JM; Song M; Kain M; Gerstenfeld L; Einhorn TA; Bouxsein ML; Tornetta P
J Orthop Res; 2007 Sep; 25(9):1193-203. PubMed ID: 17506507
[TBL] [Abstract][Full Text] [Related]
13. Effect of combined humanPTH(1-34) and calcitonin treatment in ovariectomized rats.
Washimi Y; Ito M; Morishima Y; Taguma K; Ojima Y; Uzawa T; Hori M
Bone; 2007 Nov; 41(5):786-93. PubMed ID: 17707708
[TBL] [Abstract][Full Text] [Related]
14. Repair of an intercalated long bone defect with a synthetic biodegradable bone-inducing implant.
Yoneda M; Terai H; Imai Y; Okada T; Nozaki K; Inoue H; Miyamoto S; Takaoka K
Biomaterials; 2005 Sep; 26(25):5145-52. PubMed ID: 15792541
[TBL] [Abstract][Full Text] [Related]
15. The effect of a fibrin-fibronectin/beta-tricalcium phosphate/recombinant human bone morphogenetic protein-2 system on bone formation in rat calvarial defects.
Hong SJ; Kim CS; Han DK; Cho IH; Jung UW; Choi SH; Kim CK; Cho KS
Biomaterials; 2006 Jul; 27(20):3810-6. PubMed ID: 16574220
[TBL] [Abstract][Full Text] [Related]
16. Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1-34) on chondrogenesis in a model of experimental fracture healing.
Nakazawa T; Nakajima A; Shiomi K; Moriya H; Einhorn TA; Yamazaki M
Bone; 2005 Nov; 37(5):711-9. PubMed ID: 16143574
[TBL] [Abstract][Full Text] [Related]
17. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
[TBL] [Abstract][Full Text] [Related]
18. Can TGF-beta1 and rhBMP-2 act in synergy to transform bone marrow stem cells to discogenic-type cells?
Kuh SU; Zhu Y; Li J; Tsai KJ; Fei Q; Hutton WC; Yoon ST
Acta Neurochir (Wien); 2008 Oct; 150(10):1073-9; discussion 1079. PubMed ID: 18781274
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone and bisphosphonate have opposite effects on stress fracture repair.
Sloan AV; Martin JR; Li S; Li J
Bone; 2010 Aug; 47(2):235-40. PubMed ID: 20580684
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of bone formation with an in situ setting tricalcium phosphate/rhBMP-2 composite in rats.
Niedhart C; Maus U; Redmann E; Schmidt-Rohlfing B; Niethard FU; Siebert CH
J Biomed Mater Res A; 2003 Apr; 65(1):17-23. PubMed ID: 12635149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
